Ekso Bionics Holdings, Inc. Stock
Equities
EKSO
US2826443010
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -2.34% | -5.30% | -50.00% |
Sales 2024 * | 23.5M 32.12M | Sales 2025 * | 30.5M 41.69M | Capitalization | 22.38M 30.59M |
---|---|---|---|---|---|
Net income 2024 * | -9M -12.3M | Net income 2025 * | -5M -6.83M | EV / Sales 2024 * | 0.95 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.73 x |
P/E ratio 2024 * |
-2.55
x | P/E ratio 2025 * |
-5.21
x | Employees | 71 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.5% |
Latest transcript on Ekso Bionics Holdings, Inc.
1 day | -2.34% | ||
1 week | -5.30% | ||
Current month | -8.09% | ||
1 month | -11.97% | ||
3 months | -43.69% | ||
6 months | +56.50% | ||
Current year | -50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Davis
CEO | Chief Executive Officer | 54 | 21-03-31 |
Jerome Wong
DFI | Director of Finance/CFO | 50 | 17-04-30 |
Jason Jones
COO | Chief Operating Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corinna Lathan
BRD | Director/Board Member | 57 | 21-12-24 |
Rhonda Wallen
BRD | Director/Board Member | 57 | 20-12-28 |
Mary Cloyd
BRD | Director/Board Member | 69 | 20-12-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.25 | -2.34% | 54,722 |
24-04-25 | 1.28 | +8.47% | 105,061 |
24-04-24 | 1.18 | +1.72% | 25,894 |
24-04-23 | 1.16 | -9.38% | 130,377 |
24-04-22 | 1.28 | -3.03% | 132,388 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.00% | 22.38M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- EKSO Stock